SEC Asks Enzene Biosciences to Revise Phase III Trial Protocol for Nivolumab Biosimilar
- 12 October 2025
- 2 weeks ago
Jubilant HollisterStier unveils high speed Isolator based Line at Spokane facility in US
- 12 October 2025
- 2 weeks ago
Natco Pharma appoints G Vijay Kiran Kumar as VP- Corporate Quality Assurance (Formulations)
- 12 October 2025
- 2 weeks ago
Kerala RCC Blacklists Globela Pharma After Brain Cancer Drug Found in Wrong Packaging
- 12 October 2025
- 2 weeks ago
Coldrif cough syrup banned in Delhi
- 11 October 2025
- 3 weeks ago
Coldrif fallout: How a Pharma firm skipped India's Drug Watchdog inspections
- 11 October 2025
- 3 weeks ago
CDSCO Panel seeks clarifications from Novo Nordisk on IcoSema phase IIIb clinical study protocol
- 11 October 2025
- 3 weeks ago
Recent News
Madras HC grants bail to man accused of forging NE...
- 01 November, 2025
AIIMS INI SS January 2026: 4 seats added in 2 spec...
- 01 November, 2025
Treatment in Myocardial Infarction and Non-Obstruc...
- 01 November, 2025
PG medical admissions 2025 commence in Bihar, chec...
- 01 November, 2025
Assam to begin NEET PG 2025 counselling from Novem...
- 01 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.









